LAB 240816 2.50C (LAB240816C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

LAB240816C2500

Watchlist

0.03
-0.02-40.00%

15min DelayClose Aug 15 16:00 ET

0.05High0.03Low

Intraday

5D
Daily

News

$1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
BenzingaAug 12 09:07 ET
Standard BioTools Second Quarter 2024 Earnings: Misses Expectations
Yahoo FinanceAug 9 06:56 ET
Standard BioTools | 10-Q: Q2 2024 Earnings Report
SEC announcementAug 6 16:35 ET · Announcements
Standard BioTools to Participate in Upcoming Investor Conferences
GlobeNewswireAug 6 16:01 ET
Standard BioTools Inc. (NASDAQ:LAB) Analysts Just Slashed This Year's Revenue Estimates By 15%
Yahoo FinanceAug 5 14:41 ET
Standard BioTools Inc. (NASDAQ:LAB) Just Reported And Analysts Have Been Cutting Their Estimates
Yahoo FinanceAug 4 09:19 ET

Comments

MARKET-TEST-DUMMY

Jul 25 09:18

Insider buying

$Standard BioTools (LAB.US)$

MARKET-TEST-DUMMY

Jun 5 15:13

Keep trying

$Standard BioTools (LAB.US)$

Trytosaveabit

May 28 15:05

Hmm

$Standard BioTools (LAB.US)$ Standard BioTools Purchases the Carterra® Lsa-Xt System to Accelerate Data Delivery and Provide Greater Validation to Somascan Customers

Trytosaveabit

May 8 15:23

Decent

$Standard BioTools (LAB.US)$ Revenue was $46 million, up 81% year-over-year, with impact of SomaScan
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.

Trytosaveabit

Apr 8 07:03

Update

$Standard BioTools (LAB.US)$ Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE